SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $49,606.20 in Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,937 shares of SI-BONE stock in a transaction on Monday, November 18th. The shares were sold at an average price of $12.60, for a total value of $49,606.20. Following the transaction, the insider now owns 228,554 shares of the company’s stock, valued at $2,879,780.40. The trade was a 1.69 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

SI-BONE Stock Performance

Shares of SIBN opened at $12.56 on Friday. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a one year low of $11.70 and a one year high of $21.70. The business has a fifty day moving average of $13.72 and a 200 day moving average of $14.22.

Hedge Funds Weigh In On SI-BONE

A number of hedge funds have recently modified their holdings of the company. Bellevue Group AG increased its holdings in shares of SI-BONE by 810.5% in the first quarter. Bellevue Group AG now owns 1,139,956 shares of the company’s stock worth $18,661,000 after purchasing an additional 1,014,756 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in shares of SI-BONE by 222.5% in the third quarter. Harbor Capital Advisors Inc. now owns 620,490 shares of the company’s stock valued at $8,674,000 after acquiring an additional 428,110 shares during the period. American Century Companies Inc. lifted its holdings in shares of SI-BONE by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after acquiring an additional 368,637 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in shares of SI-BONE by 14.7% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock worth $39,145,000 after purchasing an additional 358,821 shares during the period. Finally, Paradigm Capital Management Inc. NY grew its holdings in SI-BONE by 24.7% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company’s stock valued at $17,448,000 after purchasing an additional 267,100 shares during the last quarter. 98.11% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

SIBN has been the topic of a number of recent analyst reports. Morgan Stanley cut their price target on shares of SI-BONE from $21.00 to $19.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Truist Financial boosted their price target on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $19.00 price objective on shares of SI-BONE in a research report on Wednesday. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of $23.00.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.